Found 6 matching trials
Phase 1 Study of WBRT or PCSI With REYOBIQ for Leptomeningeal Metastases PHASE1 This Phase 1 study is designed to assess the safety, tolerability, and sche...
Show More Location
Multiple Locations
Learn More & Join Trial
Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT) PHASE1 This is a multi-center, sequential cohort, open-label, volume and dose esca...
Show More Location
Northshore University Hospital
Learn More & Join Trial
Safety & Efficacy/Tolerability of Rhenium-186 NanoLiposomes (186RNL) for Patients Who Received a Prior 186RNL Treatment PHASE1 This is an open-label, multicenter, Phase 1 study to establish the safety a...
Show More Location
The Cancer Therapy and Research Center at UTHSCSA
Learn More & Join Trial
Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases PHASE1 This is an open-label Phase I clinical study that will administer a single ...
Show More Status
Active Not Recruiting
Location
Northwestern Memorial Hospital Olson Pavilion
Learn More & Join Trial
Determine Maximum Tolerated Dose, Safety, and Tolerability of Rhenium (186Re) in Pediatric Recurrent, Refractory or Progressive Ependymoma and High-Grade Glioma PHASE1 Pediatric patients 6-21 years of age with supratentorial recurrent, refract...
Show More Location
Multiple Locations
Learn More & Join Trial
Multiple Dose Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases PHASE1 This is an open-label, multicenter, Phase 1 study to determine the safety a...
Show More Location
The Cancer Therapy and Research Center at UTHSCSA
Learn More & Join Trial